Squarepoint Portfolio holdings
AUM
$45.5B
1-Year Return
6.73%
This Quarter Return
+14.59%
1 Year Return
+6.73%
3 Year Return
+22.51%
5 Year Return
+41.07%
10 Year Return
+76.91%
AUM
$11.4B
AUM Growth
+$4.41B
(+63%)
Cap. Flow
+$3.29B
Cap. Flow
% of AUM
28.8%
Top 10 Holdings %
Top 10 Hldgs %
28.58%
Holding
3,090
New
813
Increased
713
Reduced
942
Closed
605
Top Buys
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.54B |
| 2 |
SPDR S&P 500 ETF Trust
SPY
|
+$460M |
| 3 |
Apple
AAPL
|
+$220M |
| 4 |
Amazon
AMZN
|
+$189M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$152M |
Top Sells
| 1 |
Intuit
INTU
|
+$55.6M |
| 2 |
Lowe's Companies
LOW
|
+$44.8M |
| 3 |
CVS Health
CVS
|
+$39.2M |
| 4 |
Eli Lilly
LLY
|
+$37M |
| 5 |
Southern Company
SO
|
+$31.3M |
Sector Composition
| 1 | Technology | 17.01% |
| 2 | Consumer Discretionary | 13.59% |
| 3 | Healthcare | 10.15% |
| 4 | Financials | 7.96% |
| 5 | Industrials | 6.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1676
Aramark
ARMK
$10.1B
| $391K | ﹤0.01% |
14,056
-846,913
| -98% | -$23.6M |
|
1677
Pathward Financial
CASH
$1.72B
| $391K | ﹤0.01% |
+10,692
| New | +$391K |
|
1678
e.l.f. Beauty
ELF
$7.67B
| $391K | ﹤0.01% |
15,513
-1,172
| -7% | -$29.5K |
|
1679
Generation Bio
GBIO
$39.9M
| $391K | ﹤0.01% |
+1,378
| New | +$391K |
|
1680
Janus Henderson
JHG
$7.01B
| $390K | ﹤0.01% |
+12,005
| New | +$390K |
|
|
EGRX
1681
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $390K | ﹤0.01% |
8,381
-4,953
| -37% | -$230K |
|
1682
BeyondSpring
BYSI
$73.4M
| $388K | ﹤0.01% |
+31,802
| New | +$388K |
|
1683
Neurocrine Biosciences
NBIX
$14.1B
| $388K | ﹤0.01% |
4,044
-9,795
| -71% | -$940K |
|
1684
Nomad Foods
NOMD
$2.12B
| $388K | ﹤0.01% |
+15,273
| New | +$388K |
|
|
USX
1685
DELISTED
U.S. Xpress Enterprises, Inc. Class A Common Stock
USX
| $388K | ﹤0.01% |
56,795
-40,209
| -41% | -$275K |
|
|
SMED
1686
DELISTED
Sharps Compliance Corp
SMED
| $388K | ﹤0.01% |
41,070
-1,696
| -4% | -$16K |
|
1687
Coherus Oncology, Inc. Common Stock
CHRS
$150M
| $387K | ﹤0.01% |
+22,254
| New | +$387K |
|
|
CSII
1688
DELISTED
Cardiovascular Systems, Inc.
CSII
| $387K | ﹤0.01% |
8,845
-17,022
| -66% | -$745K |
|
1689
Axogen
AXGN
$755M
| $386K | ﹤0.01% |
21,551
+3,596
| +20% | +$64.4K |
|
1690
Codexis
CDXS
$219M
| $386K | ﹤0.01% |
17,680
-31,614
| -64% | -$690K |
|
1691
RE/MAX Holdings
RMAX
$195M
| $385K | ﹤0.01% |
+10,587
| New | +$385K |
|
1692
Emcor
EME
$28.2B
| $384K | ﹤0.01% |
4,200
-16,737
| -80% | -$1.53M |
|
1693
Limbach Holdings
LMB
$1.23B
| $384K | ﹤0.01% |
+31,155
| New | +$384K |
|
|
ABMD
1694
DELISTED
Abiomed Inc
ABMD
| $383K | ﹤0.01% |
+1,182
| New | +$383K |
|
|
AFMD
1695
DELISTED
Affimed
AFMD
| $381K | ﹤0.01% |
6,554
-7,917
| -55% | -$460K |
|
1696
Cabaletta Bio
CABA
$168M
| $380K | ﹤0.01% |
30,455
-22,844
| -43% | -$285K |
|
1697
Mid-America Apartment Communities
MAA
$16.6B
| $380K | ﹤0.01% |
3,001
-1,484
| -33% | -$188K |
|
1698
Montrose Environmental
MEG
$1.05B
| $380K | ﹤0.01% |
+12,279
| New | +$380K |
|
|
AVDL
1699
Avadel Pharmaceuticals
AVDL
$1.5B
| $379K | ﹤0.01% |
56,666
-4,499
| -7% | -$30.1K |
|
1700
Hamilton Beach Brands
HBB
$196M
| $379K | ﹤0.01% |
+21,657
| New | +$379K |
|